Paul stirred up controversy before the Royal Rumble, making an ultimatum to WWE management regarding his number 30 spot. Rumors had swirled that Johnson, with his high-ranking role at TKO (WWE's ...

In the Round of 16 at the Dallas Open on Thursday, Tommy Paul (ranked No. 9) takes on Ethan Quinn (No. 199). Paul claimed a three-set victory over Jenson Brooksby (6-7, 6-3, 6-4) in the Round of ...

HONG KONG, Jan 20 (Reuters) - British investment bank Barclays (BARC.L), opens new tab said on Monday it has appointed former Goldman Sachs banker Paul Johnson as head of equities for Asia Pacific.

On his show, "The Paul Finebaum Show," he stated that he does not view Ewers as a potential NFL starter. "Quinn Ewers will be very good as a high placeholder for point after attempts in the NFL ...

The interim head coach shed some light on how the position has adapted and expanded since Chris Paul was drafted. Specifically, Johnson noted a shift from rigid positional definitions to a more ...

(Bloomberg) -- Barclays Plc hired Paul Johnson from Goldman Sachs Group Inc., as head of equities for Asia-Pacific, part of its three-year plan to boost its equities franchise in the region.

However, this may not be true for Texas Longhorns quarterback Quinn Ewers. Ewers has not officially ... Despite this, ESPN's Paul Finebaum stated on his show, "The Paul Finebaum Show," that ...

Paul Mango, former Deputy Chief of Staff for Policy at the U.S. Department of Health and Human Services (HHS) and former Chief of Staff at the Centers for Medicare and Medicaid Services (CMS ...

HONG KONG (Reuters) - British investment bank Barclays said on Monday it has appointed former Goldman Sachs banker Paul Johnson as head of equities for Asia Pacific. Based in Hong Kong, Johnson will ...

Combat sports stars Jake Paul, Logan Paul and Conor McGregor will be among the attendees at Donald Trump's presidential inauguration ceremony in Washington. McGregor arrived in the nation's ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...